首页> 美国卫生研究院文献>World Journal of Gastroenterology >Experimental study of therapeutic efficacy of Baicalin in rats with severe acute pancreatitis
【2h】

Experimental study of therapeutic efficacy of Baicalin in rats with severe acute pancreatitis

机译:黄ical苷治疗重症急性胰腺炎的实验研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AIM: To observe the therapeutic efficacy of Baicalin in rats with severe acute pancreatitis (SAP) and explore its therapeutic mechanisms.METHODS: The SAP rat models were randomly divided into the model control group, Baicalin treatment group, octreotide treatment group and sham operation group. All groups were randomly subdivided into 3 h, 6 h and 12 h groups with 15 rats in each group. The survival, ascites volume and pathological changes of pancreas in all rats were observed at different time points after operation. The plasma amylase content and serum TNF-α, IL-6, malonaldehyde (MDA) and PLA2 contents were also determined.RESULTS: The survival was not obviously different between the treated groups, and was significantly higher in treated groups at 12 h compared to the model control group (P < 0.05, 15 vs 10). The ascites/body weight ratio at 3 h and 6 h was significantly lower in Baicalin treatment group compared to the model control group and octreotide treatment group (P < 0.05, 1.00 vs 2.02 and 1.43 and P < 0.001, 2.29 (1.21) vs 2.70 (0.80) and 2.08 (2.21), respectively). The contents of amylase, TNF-α, IL-6, MDA and PLA2 were significantly lower in the treated groups than in the model control group (P < 0.05, 4342 vs 5303, 5058 vs 6272 in amylase, P < 0.01, 21.90 vs 36.30, 23.80 vs 39.70, 36 vs 54.35 in MDA and 56.25 vs 76.10 in PlA2, or P < 0.001, 65.10 and 47.60 vs 92.15 in TNF-α, 3.03 vs 5.44, 2.88 vs 6.82, 2.83 vs 5.36 in IL-6, respectively). The pathological scores of pancreas in the treated groups were significantly lower than that in the model control group (P < 0.05, 9.00 vs 10.05, 6.00 vs 9.00, 8.00 vs 10.05), but no marked difference was found between the treated groups.CONCLUSION: The Baicalin injection has significant therapeutic effects on SAP rats, its effects are similar to those of octreotide. The Baicalin injection is also cheap and has a big application range, quite hopefully to be used in clinical treatment of SAP.
机译:目的:观察黄ical苷对重症急性胰腺炎(SAP)大鼠的治疗作用,并探讨其治疗机制。方法:将SAP大鼠模型随机分为模型对照组,黄ical苷治疗组,奥曲肽治疗组和假手术组。 。将所有组随机分为3小时,6小时和12小时组,每组15只大鼠。术后不同时间点观察所有大鼠胰腺的存活,腹水量和病理变化。同时测定血浆淀粉酶含量,血清TNF-α,IL-6,丙二醛(MDA)和PLA2含量。结果:各治疗组的生存率无明显差异,与第12 h相比,治疗组明显高于对照组。模型对照组(P <0.05,15 vs 10)。与模型对照组和奥曲肽治疗组相比,黄ical苷治疗组在3 h和6 h的腹水/体重比显着降低(P <0.05、1.00与2.02和1.43,P <0.001、2.29(1.21)与2.70。 (分别为0.80和2.08(2.21))。与模型对照组相比,治疗组的淀粉酶,TNF-α,IL-6,MDA和PLA2含量显着降低(淀粉酶的P <0.05、4342 vs 5303、5058 vs 6272,P <0.01、21.90 vs MDA中分别为36.30、23.80与39.70、36与54.35,PlA2为56.25与76.10,或者TNF-α中P <0.001、65.10和47.60与92.15、3.03 vs 5.44、2.88 vs < / em> 6.82和2.83 vs 在IL-6中分别为5.36)。治疗组胰腺病理评分明显低于模型对照组( P <0.05,9.00 vs 10.05,6.00 vs 9.00,8.00 vs 10.05),但治疗组之间无明显差异。结论:黄ical苷注射液对SAP大鼠有明显的治疗作用,其作用与奥曲肽相似。黄ical苷注射剂也便宜并且具有大的应用范围,非常希望将其用于SAP的临床治疗中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号